| 1999 |
GBF1 was identified as a novel Golgi-associated guanine nucleotide exchange factor (GEF) with a Sec7 domain that exhibits BFA-resistant GEF activity specific towards ARF5 at physiological Mg2+ concentration. Overexpression conferred BFA resistance to Golgi morphology and ARF activation/COPI recruitment. GBF1 localized primarily to the cytosol with a pool co-localizing with β-COPI at a perinuclear (Golgi) structure. |
Expression cloning, in vitro GEF assay with His-tagged GBF1, immunogold EM localization, BFA resistance functional assay |
The Journal of cell biology |
High |
10402461
|
| 2004 |
GBF1 cycles rapidly on and off Golgi membranes (not stably associated). BFA, acting as an uncompetitive inhibitor binding to an Arf-GDP–GBF1 complex, stabilizes GBF1 on Golgi membranes. GBF1 exchange activity on Arf1 is inhibited by BFA in mammalian cells. |
YFP-GBF1 FRAP analysis, in vivo Arf1-GTP level assay, BFA treatment |
Molecular biology of the cell |
High |
15616190
|
| 2003 |
GBF1 physically interacts with the membrane-tethering protein p115 through the proline-rich region of GBF1 and the head region of p115. The two proteins colocalize at the Golgi and peripheral VTCs. Expression of the p115-binding (pro-rich) region of GBF1 causes Golgi disruption, indicating functional relevance of this interaction. |
Yeast two-hybrid screen, in vitro binding assay, in vivo co-immunoprecipitation, mutagenesis, immunofluorescence |
EMBO reports |
High |
12634853
|
| 2005 |
GBF1 rapidly cycles between membranes and cytosol (t1/2 ~17 s by FRAP), faster than ARF itself. GBF1 is stabilized on membranes when in complex with ARF-GDP (shown by inactive E794K mutant, ARF1-T31N mutant, and BFA treatment). GBF1 dissociation is triggered by its own catalytic activity (GDP displacement and GTP binding to ARF), implying each GBF1 membrane association catalyzes a single ARF activation event. |
GFP-GBF1 FRAP, dominant-negative mutant expression, BFA treatment |
Traffic (Copenhagen, Denmark) |
High |
15813748
|
| 2006 |
GBF1 localizes to both cis-Golgi membranes and peripheral puncta (VTCs) near but separate from ER exit sites. Live-cell imaging showed rapid GFP-GBF1 exchange with a large cytosolic pool. Microinjection of anti-GBF1 antibodies specifically caused dissociation of COPI from membranes, demonstrating GBF1 regulates COPI membrane recruitment in the early secretory pathway. |
GFP-live imaging, FRAP, BFA treatment, anti-GBF1 microinjection, subcellular fractionation |
Journal of cell science |
High |
16926190
|
| 2006 |
The enterovirus 3A protein inhibits Arf1 activation and COP-I coat recruitment by directly interacting with the N-terminus of GBF1 and inhibiting its GEF function. This 3A–GBF1 interaction is the mechanism by which 3A blocks ER-to-Golgi transport. |
Co-immunoprecipitation, dominant-negative Arf1 expression, siRNA knockdown, EM, in vivo transport assay, mouse virulence assay |
Developmental cell |
High |
16890159
|
| 2007 |
GBF1 acts as a Rab1b effector: active GTP-locked Rab1b (Rab1bQ67L) increases GBF1 and COPI association with peripheral ER exit site structures and stabilizes Arf1 on Golgi membranes. Rab1b siRNA knockdown reduced GBF1 membrane association. The N-terminal domain of GBF1 mediates its interaction with Rab1b. |
Co-immunoprecipitation, siRNA knockdown, live-cell GFP imaging, FRAP, dominant-active Rab1b mutant expression |
Molecular biology of the cell |
High |
17429068
|
| 2007 |
GBF1 dimerizes through its DCB domain; DCB–DCB homodimerization and DCB–HUS interactions define the N-terminal architecture of GBF1 (and BIG ArfGEFs). The HUS box (most conserved motif after Sec7) mediates the DCB–HUS interaction within each homodimer. Both DCB and HUS domains are necessary for GBF1 dimerization in mammalian cells. |
Yeast two-hybrid, biochemical interaction assays, co-immunoprecipitation in mammalian cells, mutagenesis |
The Journal of biological chemistry |
High |
17640864
|
| 2007 |
Molecular determinants of 3A–GBF1 interaction: 3A must dimerize to bind GBF1; a conserved N-terminal region of 3A is critical for GBF1 binding but not dimerization. Within GBF1, the extreme N-terminus, the DCB (dimerization/cyclophilin binding) domain, and the HUS domain are required for interaction with 3A. |
3A mutagenesis, co-immunoprecipitation, GBF1 deletion mutant analysis |
Journal of virology |
High |
17329336
|
| 2007 |
GBF1 is required for GGA (Golgi-localized, gamma-ear-containing, ARF-binding protein) recruitment to Golgi membranes. GBF1 co-localizes and co-immunoprecipitates with GGAs. Depletion of GBF1 or expression of inactive GBF1 prevents GGA membrane recruitment and causes missorting of lysosomal cargo (mannose-6-phosphate receptor, sortilin). |
Co-immunoprecipitation, GBF1 siRNA knockdown, dominant-negative GBF1, cargo trafficking assay |
Traffic (Copenhagen, Denmark) |
High |
17666033
|
| 2007 |
GBF1 depletion by siRNA causes COPI dispersal and extensive tubulation of cis-Golgi without complete Golgi collapse into ER. This causes dramatic inhibition of transmembrane protein trafficking but soluble protein secretion continues, indicating GBF1-mediated ARF activation and COPI recruitment are specifically required for transmembrane cargo but not soluble cargo transport. |
siRNA knockdown, immunofluorescence, live-cell trafficking assays, EM |
Journal of cell science |
High |
17956946
|
| 2007 |
GBF1 regulates COPI recruitment specifically on cis-Golgi compartments (not TGN), whereas BIG proteins regulate adaptor proteins on trans-Golgi. GBF1/COPI knockdown does not prevent ER export but causes VSVGtsO45 accumulation in peripheral VTCs. GBF1 is required for Golgi subcompartmentalization and cargo progression to the cell surface. |
siRNA knockdown (GBF1, BIG1, BIG2, COPI), immunofluorescence, VSVGtsO45 trafficking assay |
Molecular biology of the cell |
High |
18003980
|
| 2008 |
GBF1 depletion (but not BIG1 or BIG2 depletion) causes cell-cycle arrest in G0/G1, Golgi marker dispersal, ER stress (elevated calreticulin, PDI, ER chaperones), and triggers ATF6 proteolysis mimicking an unfolded protein response. GBF1 depletion causes relocalization of S2P from Golgi to ER with ATF6 cleavage and upregulation of ERSE genes. |
Selective siRNA depletion of each GEF, proteomic analysis, immunofluorescence, cell-cycle analysis |
Proceedings of the National Academy of Sciences of the United States of America |
High |
18287014
|
| 2008 |
Class II ARFs (Arf4, Arf5) associate with ERGIC membranes through GBF1-independent binding sites in their GDP-bound form, whereas class I Arfs (Arf1, Arf3) rapidly dissociate from all endomembranes upon BFA treatment. Loss of Arf-GTP (not formation of Arf·GDP·BFA·GBF1 complex) causes GBF1 accumulation on membranes. |
Live-cell imaging of fluorescently tagged Arfs, BFA and Exo1 treatment, GDP-locked Arf4 mutant |
Molecular biology of the cell |
High |
18524849
|
| 2008 |
GBF1 (but not BIG1 or BIG2) is critically required for mouse hepatitis coronavirus (MHV) RNA replication. ARF1, the cellular effector of GBF1, is also required. GBF1-mediated ARF1 activation controls the number of viral replication complexes formed. |
Individual siRNA knockdown of GBF1, BIG1, BIG2, ARF1; BFA sensitivity in MDCK cells expressing BFA-resistant GBF1; immunofluorescence and quantitative EM |
PLoS pathogens |
High |
18551169
|
| 2009 |
GBF1 is critically required for CVB3 RNA replication. BFA-resistant GBF1-M832L rescues replication in BFA-treated cells; GBF1 knockdown by RNAi inhibits replication; only active (not inactive catalytic mutant) GBF1 rescues replication. Overexpression of ARF proteins or Rab1B did not rescue BFA-inhibited replication. |
siRNA knockdown, BFA-resistant GBF1 mutant rescue, overexpression of Arf proteins and Rab1B, replicon assays |
Journal of virology |
High |
19740986
|
| 2009 |
GBF1 is a host factor critically required for HCV RNA replication. GBF1 knockdown (but not BIG1 or BIG2) inhibits HCV replication. BFA-resistant GBF1 mutant rescues HCV replication in BFA-treated cells. BFA/GBF1 inhibition does not block membranous web formation but impairs replication complex activity. |
siRNA knockdown of individual GEFs, BFA-resistant GBF1 rescue, pharmacological GBF1 inhibitor, immunofluorescence and EM |
Journal of virology |
High |
19906930
|
| 2009 |
Drosophila garz (ortholog of GBF1) is a novel component of the clathrin-independent GEEC endocytic pathway, required for GPI-anchored protein and fluid-phase internalization. A catalytically inactive GBF1 GEF mutant has altered Arf1 activation at nascent pinosomes and impairs fluid-phase uptake. |
RNAi screen, live confocal and TIRF imaging with GBF1-GFP and Arf1 sensor, GEF-dead mutant, quantitative endocytosis assays |
PloS one |
High |
19707569
|
| 2010 |
For poliovirus replication, the N-terminal region of GBF1 (lacking the catalytic Sec7 domain) is sufficient to rescue BFA-inhibited replication. In infected cells p115 is degraded and neither p115 nor Rab1b knockdown affects viral replication, indicating viral replication requires a non-catalytic function of GBF1 distinct from its cellular role in ARF/COPI secretory trafficking. |
N-terminal GBF1 truncation rescue assay, p115/Rab1b siRNA knockdown, BFA-resistant virus replicon |
Cellular microbiology |
High |
20497182
|
| 2010 |
GBF1 is phosphorylated by CDK1-cyclin B during mitosis, causing its dissociation from Golgi membranes and reduction of membrane-associated GTP-bound ARF. A low level of GBF1 activity persists in mitosis and remains required for COPI recruitment, suggesting GBF1 phosphorylation and membrane dissociation contribute to Golgi fragmentation during mitotic entry. |
Phosphoprotein analysis, CDK1-cyclin B in vitro kinase assay, immunofluorescence in mitotic cells, ARF-GTP measurement |
The Biochemical journal |
High |
20175751
|
| 2010 |
PI4KIIIα-generated phosphatidylinositol 4-phosphate [PtdIns(4)P] is required for GBF1 recruitment to Golgi membranes. Dominant-active Rab1 increases PtdIns(4)P levels at the Golgi, suggesting Rab1 contributes to GBF1 recruitment specificity by activating PI4KIIIα to produce PtdIns(4)P. |
PI4KIIIα siRNA knockdown, PI4P inhibitors (wortmannin, LY294002), GFP-PH PtdIns(4)P sensor, dominant-active Rab1 expression, GBF1 localization assay |
Journal of cell science |
High |
20530568
|
| 2011 |
C. trachomatis selectively co-opts GBF1 (but not BIG1 or BIG2) for vesicle-mediated sphingomyelin (SM) acquisition. The Arf1/GBF1-dependent SM pathway is essential for inclusion membrane growth and stability but not for bacterial replication. GBF1 depletion by siRNA blocks SM delivery to the inclusion. |
siRNA knockdown of individual BFA targets, BFA sensitivity analysis, fluorescent SM trafficking assay, inclusion integrity measurement |
PLoS pathogens |
High |
21909260
|
| 2011 |
GBF1 and ATGL (adipose triglyceride lipase) interact directly through multiple contact sites: ATGL C-terminus contacts GBF1 N-terminal domains including the Sec7 domain; ATGL N-terminal patatin domain interacts with GBF1 HDS1 and HDS2 domains. GBF1 HDS1 and HDS2 domains localize to lipid droplets when expressed alone. The GBF1–Arf1–COPI pathway is required for ATGL delivery to lipid droplets. |
Yeast two-hybrid, co-immunoprecipitation in mammalian cells, direct protein binding (in vitro), GFP domain-localization assays |
PloS one |
High |
21789191
|
| 2012 |
ARF1 and GBF1 generate a PI4P-enriched environment at HCV replication complexes. ARF1 and GBF1 colocalize with PI4KIIIβ and are both required for HCV replication. HCV replication is inhibited by PI4P phosphatase Sac1 overexpression. |
Co-immunoprecipitation/colocalization, PI4P sensor, Sac1 overexpression, siRNA knockdown |
PloS one |
Medium |
22359663
|
| 2012 |
GBF1 bears a novel phosphatidylinositol-phosphate binding module (BP3K) that links PI3Kγ activity with Arf1 activation in GPCR-stimulated neutrophil chemotaxis. Upon GPCR stimulation, GBF1 translocates from Golgi to the leading edge via PI3Kγ product binding, where it activates Arf1 and recruits p22phox and GIT2, thereby regulating directional sensing and superoxide production. |
Subcellular fractionation, GFP-GBF1 live imaging, phospholipid binding assay, siRNA knockdown, GPCR stimulation |
Molecular biology of the cell |
High |
22573891
|
| 2013 |
GBF1's HDS1 domain (immediately downstream of the Sec7 domain) contains an amphipathic helix that binds lipid droplets and Golgi membranes in cells, and bilayer liposomes and artificial droplets in vitro. The Sec7 domain inhibits the HDS1 lipid-droplet binding capacity in the context of full-length GBF1. |
In vitro liposome binding, artificial droplet binding, GFP domain expression in cells, mutagenesis of amphipathic helix |
Journal of cell science |
High |
23943872
|
| 2013 |
GBF1-activated ARF4 and ARF5 (but not ARF3) facilitate BIG1 and BIG2 recruitment to the TGN, establishing a functional GEF cascade. GBF1 localizes ultrastructurally to pre-Golgi, Golgi, and TGN. This defines a sequential coating pathway in which GBF1 at the TGN activates ARFs that then recruit BIG1/2. |
Immunoelectron microscopy, siRNA knockdown, Arf isoform-specific rescue experiments, GBF1 inhibitor treatment |
The Journal of biological chemistry |
High |
23386609
|
| 2013 |
AMPK phosphorylates GBF1 during mitosis, causing GBF1 dissociation from the Golgi membrane and abolishing GBF1's Arf1-GEF activity, thereby promoting Golgi disassembly required for mitosis entry. |
In vitro AMPK kinase assay on GBF1, phospho-specific analysis, mitotic cell fractionation, dominant-negative and pharmacological approaches |
Journal of cell science |
High |
23418352
|
| 2015 |
The Dengue virus GBF1–Arf1/Arf4–COPI pathway is required for capsid protein transport from ER membrane to lipid droplets, independently of COPII components and Golgi integrity. A BFA-resistant GBF1 mutant rescues capsid subcellular distribution in BFA-treated infected cells. |
BFA and GCA pharmacological inhibition, BFA-resistant GBF1 rescue, siRNA knockdown, immunofluorescence |
Traffic (Copenhagen, Denmark) |
High |
26031340
|
| 2015 |
GBF1 oligomerization (mediated by the DCB domain residues K91 and E130) is dispensable for Golgi targeting, rapid membrane cycling, ARF activation, COPI recruitment, and cargo secretion. However, oligomerization stabilizes GBF1 protein; the non-oligomerizing 91/130 mutant is degraded faster than wild-type. |
GBF1 DCB domain mutagenesis, live-cell FRAP, ARF activation assay, COPI immunofluorescence, secretion assay, protein stability measurement |
American journal of physiology. Cell physiology |
High |
26718629
|
| 2017 |
GBF1 and Arf4 form a functional complex with the sensory receptor rhodopsin at the photoreceptor Golgi/TGN during transport carrier biogenesis for ciliary targeting. Rhodopsin and Arf4 bind the regulatory N-terminal DCB-HUS domain of GBF1. GCA (GBF1 inhibitor) blocks this complex and prevents rhodopsin delivery to cilia without disrupting the Golgi. GBF1 also interacts with the Arf GAP ASAP1 in a GCA-resistant manner. |
Frog retina in vivo analysis, co-immunoprecipitation with recombinant human proteins, GCA inhibitor, domain binding mapping |
Journal of cell science |
High |
29025970
|
| 2018 |
GBF1 is phosphorylated on Ser292 and Ser297 by casein kinase 2 (CK2) during mitosis, enabling recognition by the F-box protein βTrCP and recruitment to the SCFβTrCP ubiquitin ligase complex, triggering GBF1 degradation. This degradation occurs at the intercellular bridge of telophase cells and is required for Golgi membrane positioning and postmitotic Golgi reformation. A non-degradable GBF1 mutant blocks Golgi cluster transport and causes cytokinesis failure. |
Phosphorylation site mutagenesis, co-immunoprecipitation with βTrCP/SCF complex, proteomics, non-degradable GBF1 mutant live imaging, cytokinesis assay |
Cell reports |
High |
29898406
|
| 2018 |
GBF1 recruitment to Golgi membranes requires the HDS1 and HDS2 domains and a heat-labile, protease-sensitive Golgi-localized protein receptor. Arf-GDP localization at the cis-Golgi (but not TGN) promotes GBF1 recruitment. ArfGAP2 and ArfGAP3 do not regulate GBF1 recruitment. |
In vitro GBF1 recruitment assay with Golgi fractions, heat/protease treatment of membranes, Arf-GDP targeted mutants, GBF1 HDS1/HDS2 domain mapping |
Journal of cell science |
High |
29507113
|
| 2018 |
GBF1 and its substrate Arf1 interact with the mitochondrial membrane protein Miro, regulating mitochondrial spatial organization. GBF1 inhibition promotes dynein- and Miro-dependent retrograde mitochondrial transport along microtubules toward the centrosome, causing mitochondrial network collapse. Active GTP-bound Arf1 also physically interacts with Miro. |
Co-immunoprecipitation (GBF1-Miro, Arf1-GTP-Miro), GBF1 inhibition (GCA), Miro siRNA, dynein inhibitor, electron tomography, live-cell time-lapse imaging |
Scientific reports |
High |
30459446
|
| 2018 |
Conserved residues RDR1168 and LF1266 within α-helices 2 and 6 of the HDS2 domain of GBF1 are required for GBF1 targeting to Golgi membranes. Mutations at these positions compromise Golgi homeostasis, ARF activation, secretion, and cell viability in a functional replacement assay. |
HDS2 alanine-scanning mutagenesis, BFA-resistant replacement assay, Golgi morphology, COPI recruitment, secretion assay |
American journal of physiology. Cell physiology |
High |
29443553
|
| 2019 |
C10orf76 interacts with GBF1 and rapidly cycles on and off GBF1-positive Golgi structures (identified by BioID proximity labeling of Golgi-enriched fractions). C10orf76 depletion causes Golgi fragmentation, alters GBF1 recruitment, and impairs secretion. |
BioID proximity labeling, mass spectrometry, co-immunoprecipitation, siRNA knockdown, Golgi morphology and secretion assays |
Molecular & cellular proteomics : MCP |
High |
31519766
|
| 2019 |
GBF1 is required for VWF (von Willebrand factor) and extracellular matrix protein trafficking from ER to Golgi secretory granules in endothelial cells. GBF1 level is a limiting factor in VWF granule biogenesis. AMPK activation (by glucose levels) couples to GBF1 function and modulates VWF trafficking, linking physiological energy status to anterograde secretory pathway regulation. |
GBF1 siRNA knockdown, GBF1 overexpression, AMPK pharmacological activation, fluorescence live imaging of VWF trafficking, secretion assay |
Developmental cell |
High |
31056345
|
| 2019 |
HCV NS3 protein directly interacts with GBF1 through the Sec7 domain of GBF1 and the protease domain of NS3, as shown by yeast two-hybrid, co-immunoprecipitation, and proximity ligation assay. NS3 alters GBF1 intracellular localization. An NS3 mutant (N77D) that disrupts GBF1 binding is non-replicative despite retaining protease activity, indicating the NS3–GBF1 interaction is important for HCV genome replication. |
Yeast two-hybrid, co-immunoprecipitation, proximity ligation assay, NS3 mutagenesis, replication assay |
Journal of virology |
High |
30567983
|
| 2019 |
GBF1 catalytic activity (but not Arf1 activation per se) is essential for rotavirus assembly. Inhibition of GBF1 by BFA or GCA prevents trimerization of the outer capsid protein VP7 and blocks assembly of triple-layered particles. GBF1 inhibition alters electrophoretic mobility of VP7 and NSP4. |
BFA and GCA pharmacological inhibition, GBF1 siRNA knockdown, viral particle characterization, VP7 trimerization assay |
Journal of virology |
High |
31270230
|
| 2019 |
Multiple determinants in GBF1 support poliovirus replication: the Arf-activating property of the Sec7 domain is indispensable, but the primary structure of the Sec7 domain itself is not. GBF1 is recruited to replication sites via both direct 3A interaction and redundant determinants in C-terminal non-catalytic domains (HDS regions). |
GBF1 domain mutant rescue assay in poliovirus replication context, viral RNA replication assay, BFA-resistant rescue |
Journal of virology |
High |
31375590
|
| 2021 |
Src kinase phosphorylates GBF1 on 10 tyrosine residues; two residues (Y876 and Y898) near the C-terminus of the Sec7 domain promote GBF1 binding to Arf1 GTPase. This phosphorylation induces formation of tubular transport carriers containing GALNTs for Golgi-to-ER retrograde transport. Phosphomimetic GBF1 mutants induce tubules, while mutants defective for Arf1 binding prevent carrier formation and GALNTs relocation. |
Phosphoproteomics, Src kinase assay, GBF1 phosphomimetic/phosphodeficient mutants, live-cell tubule imaging, molecular modeling, Arf1 binding assay |
eLife |
High |
34870592
|
| 2024 |
AMPK associates with the Golgi and phosphorylates GBF1 at Thr1337 upon activation, causing Golgi fragmentation and slowing protein trafficking through the Golgi. Golgi disassembly upon AMPK activation is blocked in cells expressing non-phosphorylatable GBF1-T1337A generated by gene editing. |
AMPK-α knockout cells, pharmacological AMPK activators, GBF1-T1337A knock-in by gene editing, Golgi morphology assay, protein trafficking (Gaussia luciferase) assay |
Journal of cell science |
High |
39575556
|
| 2016 |
Zebrafish gbf1 loss-of-function (L1246R mutation in HDS2 domain, morphants, knockout) causes intracerebral hemorrhage due to vascular breakage in a cell-autonomous manner. The L1246R Gbf1 mutant fails to be recruited to the Golgi and cannot activate Arf1 or recruit the COPI complex in mammalian cells, indicating HDS2 domain is essential for GBF1 membrane targeting and function. |
ENU mutagenesis/positional cloning in zebrafish, gbf1 morpholino knockdown and CRISPR knockout, Gbf1-L1246R expression in mammalian cells, Golgi recruitment and Arf1 activation assay |
The Journal of biological chemistry |
High |
28003365
|
| 2020 |
Pathogenic variants in GBF1 (four distinct heterozygous variants, two de novo) cause distal hereditary motor neuropathy/Charcot-Marie-Tooth neuropathy type 2 (HMN/CMT2). Primary fibroblasts from all affected individuals show marked Golgi fragmentation consistent with GBF1's role in Golgi maintenance. GBF1 is present in mouse spinal cord/muscle and enriched at motor neurons and growth cones. |
Genomic sequencing, Golgi fragmentation assay in patient fibroblasts, immunofluorescence in mouse tissue |
American journal of human genetics |
Medium |
32937143
|
| 2023 |
Phosphorylation of specific N-terminal residues of GBF1 (S233, S371, Y377, Y515) differentially regulates its role in cytokinesis versus Golgi homeostasis/secretion: phosphomimetic mutants of these residues support normal Golgi architecture and cargo secretion but cause multi-nucleation and impair cytokinetic bridge resolution, while not affecting secretory functions. |
GBF1 phospho-site mutagenesis (phosphomimetic and non-phosphorylatable), Golgi morphology assay, secretion assay, cytokinesis/multinucleation assay |
Scientific reports |
High |
37604968
|
| 2012 |
GBF1-dependent secretion (via Arf1-COPI machinery) is required for Drosophila tubulogenesis. Loss of Garz (fly GBF1 ortholog) impairs Golgi integrity, cargo vesicle transport, and directed apical membrane delivery, causing failure in epithelial polarity and lumen expansion in tubular organs. |
Drosophila loss-of-function mutants, immunofluorescence, EM, live imaging of cargo transport |
Journal of cell science |
High |
22302994
|
| 2013 |
In C. elegans, GBF-1 (GBF1 ortholog) localizes to the cis-Golgi and is required for secretion, Golgi integrity, and ER reticular structure. GBF-1 RNAi also impairs receptor-mediated endocytosis in oocytes without affecting recycling pathways, and alters early/late endosome dynamics. |
RNAi, immunofluorescence, GFP-tagged organelle markers, yolk receptor trafficking assay in C. elegans |
PloS one |
Medium |
23840591
|
| 2021 |
GBF1 deficiency in mouse oocytes (via GBF1 inhibitor treatment) causes aberrant Golgi accumulation around the spindle, condensation of GM130 (a Golgi matrix protein co-localizing with GBF1), ER structural disruption with elevated ER stress marker GRP78, and altered mitochondrial membrane potential, impairing polar body formation. |
GBF1 inhibitor (GCA) in mouse oocytes, immunofluorescence, mitochondrial membrane potential assay, Western blot |
Microscopy and microanalysis |
Medium |
33478608
|
| 2024 |
GBF1 knockdown activates XBP1s (unfolded protein response) and enhances mTOR-independent autophagy in human lens epithelium cells. A pathological GBF1 T1287I mutation reduces GBF1 protein levels. Heterozygous Gbf1 knockout mice display cataracts, establishing GBF1 as a causative gene for congenital cataracts. |
siRNA knockdown, UPR activation assay (XBP1 splicing), autophagy assay, Gbf1 heterozygous knockout mice, patient mutation analysis |
Human genetics |
Medium |
39110251
|